Refer for the ENDOSURE Diagnostic Test
Fax this form to the patient’s preferred ENDOSURE test location.
The Only Tier 1 Diagnostic Test for Endometriosis
Canadian clinics offering ENDOSURE Test
| Clinic | Location | Lead Provider | Phone | Fax |
|---|---|---|---|---|
| Links Medical Clinic | Edmonton, AB (Mira Health Centre, #109 – 11910 111 Ave NW) | Dr. Sam Azer, OBGYN | +1 (780) 454-0351 | +1 (780) 429-0372 |
| CReATe Fertility London | London, ON (215 Fanshawe Park Road West, Suite 10) | Dr. John McNaught, OBGYN | +1 (519) 472-9333 | +1 (519) 286-0277 |
| The ENDO Health Collective | Vancouver, BC (Unit 410, 943 West Broadway) | Shani DeShield, RN, NP, Family/All Ages | +1 (778) 300-5177 | +1 (888) 834-3174 |
3-minute ENDOSURE Test
Practitioner Webinar
- ENDOSURE test, by 3CPM, is authorized for sale by Health Canada, MDALL 107153
- Provides clinical decision support for earlier diagnosis of endometriosis
- Most like ECG, but for the gut. Electroviscerography/EVG captures the GIMA biomarker of endometriosis
- Tier-1 test; non-invasive, rapid, accurate, suitable for all ages, detects all disease stages
DIAGNOSTIC SUPPORT for ENDOMETRIOSIS
- Patients under 36: 99% accuracy, 95% sensitivity, 96% specificity
- Patients 36+: 98% accuracy, 91% sensitivity, 95% specificity
- Detects all disease stages
- Detects all disease subtypes & adenomyosis
PATIENT CENTRED
- For all ages, premenarche to post menopause
- Painless & trauma informed
- Minimal patient preparation
- Patients remain fully clothed during test
- Testing takes less than an hour
Clinical Uses
- Rapid diagnosis
- Post treatment patient monitoring
- Confirming factor for infertility
- Adolescent screening
ENDOSURE provides clinical evidence If You suspect endometriosis
TIER-1 Diagnostic Test for Endometriosis
ENDOSURE is a highly accurate, yet non-invasive test that uses an electroviscerography system (EVG), an analytical instrument that collects Gastro Intestinal Myoelectrical Activity (GIMA) signals from the abdomen through dry electrodes. The test detects endometriosis presence by measuring a GIMA pattern unique to endometriosis sufferers, known as the GIMA biomarker of endometriosis. Very similar to an electrocardiogram/ECG it’s easy to perform and provides a near-instant diagnostic result using simple, objective GIMA data.
ENDOSURE test, by 3CPM, is authorized for sale by Health Canada (MDALL 107153).
ENDOSURE is a private test and not currently covered by provincial healthcare plans in Canada. Blue Cross has added ENDOSURE test coverage under extended health care plans, including fertility and family planning benefits (with referral) and through health spending accounts (HSAs) and personal spending accounts; Sunlife has added coverage for some fertility/family planning plans. Because coverage requirements, reimbursement limits, and referral criteria vary by plan, patients should review their benefits and contact their insurance provider to confirm eligibility and determine whether a healthcare provider referral or letter of support is required before scheduling the test.
Information for Providers
Patient Brochure
Talk to Us
Electroviscerography system (EVG) is an analytical instrument that collects
myoelectrical activity signals from the gastrointestinal tract (GIMA).
ENDOSURE test records patient GIMA pattern over 30-minutes, then compares data to the GIMA biomarker of endometriosis, a known digital “fingerprint” of people who suffer from endometriosis.2,3
Near-instant results support your diagnosis of endometriosis and expedite disease management.
Frequently Asked Questions
What should patients expect?
Testing is painless and takes just under an hour. Similar to an ECG but for the gut: electrodes record gastrointestinal myoelectric activity (GIMA) for 30 minutes while patient remains still and relaxed.
When should patients schedule an ENDOSURE test?
Scheduling ENDOSURE Test:
- Non-menses
- ≥2 wk post-acute GI illness
- ≥2 wk post-abdo/pelvic infection
- ≥3 mo post-abdo/pelvic surgery
- Stable/No active: celiac/crohns/ulcerative colitis/ SIBO/bowel obstruction/
GI infection sx
What are guidelines for medication restrictions for patients preparing for testing?
NPO 8h pre-EVG. Hold opioids/lisdexamfetamine x48h; antispasmodics/prokinetics/bowel stimulants x72h; THC/GLP-1 agonistsx30d pre-EVG. Cont APAP/NSAIDs/hormonal tx/antidepressants/neuropathic pain meds/antiemetics PRN.
What if a patient is diabetic?
Patient preparation includes:
-NPO 2-hours pre-test
-2-8h pre-test, allow small snack – 4oz apple/grape juice + 1 dry toast slice OR 2 rice cakes. NPO ≥2h pre-test.
– Continue all routine Rx meds unless specified otherwise. Take w/ small sips H2O if needed. NPO ≥2h pre-test.
Other instructions remain the same:
-NPO MN caffeine
-Hold opioids x 48h pre-EVG
-Hold antiemetics/antispasmodics/prokinetics/THC x 72h pre-EVG
What medications can affect the ENDOSURE test?
- Opioid pain medications that slow the bowel: Codeine, Oxycodone, Hydrocodone +/- acetaminophen, Morphine, hydromorphone, Tramadol +/- acetaminophen
- ADHD medications containing lisdexamfetamine (Vyvanse)
- Medications that change intestinal movement: Metoclopramide, Domperidone, Itopride, Levosulpiride, Erythromycin, Dicyclomine, Hyoscine butylbromide, Loperamide
- THC containing cannabis products
- GLP-1 receptor agonists that slow stomach emptying: Tirzepatide – Mounjaro, Semaglutide – Ozempic/Wegovy
What medications are usually safe to continue during an ENDOSURE test?
Acetaminophen, NSAIDs, Hormonal contraceptives, Endometriosis hormone therapy, Antidepressants, Neuropathic pain medication, Antiemetics
Can patients continue with medical marijuana?
Preparations containing THC should be discontinued 30 days prior to ENDOSURE testing.
Do I receive test results?
On the referral form, check the box to request ENDOSURE test results.
Who reviews test results with patients?
Patients generally book a separate consult with the testing clinics attending clinician to review results.
Can I rely on ENDOSURE test results?
ENDOSURE test is a highly accurate clinical tool helping clinician confidently diagnose endometriosis. Draft Guidelines from NICE (UK) now include ENDOSURE test as a first line test for endometriosis. Published results are as follows:
Females ≤35 years:
- 99% accurate
- 95% sensitivity
- 96% specificity
Females 36 years+:
- 98% accurate
- 91% sensitivity
- 95% specificity
Is the ENDOSURE test covered by provincial healthcare plans?
ENDOSURE test is only available at private clinics and is not currently covered by provincial plans (e.g. AHCIP, OHIP).
Is the ENDOSURE test covered by insurance?
Insurance coverage of ENDOSURE test is available under select Blue Cross extended health care plans, including fertility and family planning benefits (with a referral for testing) and through health spending accounts (HSAs) and personal spending accounts; SunLife offers coverage within plans that cover Endometrial Receptivity Assessment (ERA). Coverage requirements, reimbursement limits, and referral criteria vary by insurance company and plan. Patients should review their benefits and contact their insurance provider to confirm eligibility and determine whether a healthcare provider referral or letter of support is required before scheduling the test. Reimbursement normally requires a referral before testing from thier clinician.
What are the most common endometriosis symptoms?
- Dysmenorrhea, Chronic pelvic pain
- Menorrhagia
- Dysuria, Dyschezia, or Dyspareunia
- IBS, GI issues, suspected urinary infection unresponsive to treatment
- Unexplained fatigue or Brain fog
- Anxiety or depression
- Unexplained infertility
- Frequent miscarriage
- Previous high-risk pregnancy
Are there any risks associated with ENDOSURE?
There are no risks associated with this test. There are no components that are used during the test equipment that are harmful. No anesthesia is required for this test.
What Clinicians are Saying
- Dr. David Griffiths, Consultant Gynaecologist MB ChB, FRCOG
“ Until now we haven’t had a very good, simple, easy, quick, inexpensive screening test for endometriosis. Until now the only way to diagnose endometriosis definitively has been with a surgical procedure. We have the potential to crack that nut.
Larry Glazerman, MD, MBA
-Dr. Sarah Roth, ND
Published Research:
1. Mark Noar, John Mathias, Ajit Kolatkar. Validation of New GIMA Biomarker Signature of Endometriosis – Interim Data: Research Article. Advance. August 26, 2024.
DOI: 10.22541/au.172469630.08159498/v1
2. Noar M, Mathias J, Kolatkar A. Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis. J Clin Med. 2024;13(10):2866. Published 2024 May 13. doi:10.3390/jcm13102866
3. AI-Derived Threshold Score of Intraabdominal Myoelectrical Activity Predicts Presence and Stage of Endometriosis with 100% Accuracy, Noar, M., Journal of Minimally Invasive Gynecology, Volume 29, Issue 11, S4 – S5. DOI: 10.1016/j.jmig.2022.09.026
4. Tanos P, Donders F, Massaro A, Philippe S, Karampelas S. Defining the role of the gastrointestinal myoelectrical activity (GIMA) biomarker in the diagnosis of endometriosis. J Minim Invasive Gynecol. 2025;32(11)(suppl):S23. doi:10.1016/j.jmig.2025.09.027
